BioSpace News Archive

Orthodontics Market Size to Worth Around US$ 16.2 BN by 2028

The global orthodontics market size is predicted to be worth around US$ 16.2 billion by 2028 from valued at US$ 5.99 billion in 2021, growing at a CAGR of 15.3% from 2021 to 2030.

March 11, 2022
·
4 min read
Sleep Apnea Devices Market to Reach Valuation US$ 10.1 BN by 2027

The global sleep apnea devices market is expected to reach valuation of around US$ 10.1 billion by 2027, expanding growth at a CAGR of 7.1% during forecast period 2022 to 2027.

March 11, 2022
·
4 min read
Business

AbbVie and Gedeon Richter Announce Collaboration in Neuropsychiatric Diseases

AbbVie and Gedeon Richter Plc. announced a new co-development and license agreement to research, develop and commercialize novel dopamine receptor modulators for the potential treatment of neuropsychiatric diseases.

March 11, 2022
·
11 min read
Policy

Update on Status under Holding Foreign Companies Accountable Act

HUTCHMED Limited would like to provide an update on its status under the Holding Foreign Companies Accountable Act.

March 11, 2022
·
4 min read
Drug Development

Emergent BioSolutions Initiates Phase 1 Study Evaluating Potential Intranasal Treatment for Cyanide Poisoning

Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has dosed the first participant in its Phase 1 study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of stabilized isoamyl nitrite (SIAN), a treatment being developed for known or suspected acute cyanide poisoning.

March 11, 2022
·
3 min read
Deals

Oxford Biomedica broadens its viral vector capabilities with the launch of Oxford Biomedica Solutions, a full scope AAV business in Boston, following closing of its deal with Homology

Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or the “Company”), a leading gene and cell therapy group, is pleased to announce that it has completed its deal with Homology Medicines Inc.

March 11, 2022
·
4 min read
Business

Leap Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results

Leap Therapeutics, Inc. today reported financial results for the fourth quarter and year ended December 31, 2021.

March 11, 2022
·
13 min read
Business

Spectrum Pharmaceuticals to Report Fourth Quarter and Full Year 2021 Financial Results and Provide Corporate Update

Spectrum Pharmaceuticals today announced it will host a conference call to discuss the fourth quarter and full year 2021 financial results and provide a corporate update on Thursday, March 17, 2022 at 4:30 p.m. Eastern/1:30 p.m. Pacific.

March 11, 2022
·
3 min read
Lone Star Bio

Independent Data Presented at Society for Surgical Oncology Conference Demonstrated DecisionDx®-Melanoma Outperforms T-Stage at Identifying Patients with Low Risk of Sentinel Lymph Node Positivity

Independent Data Presented at Society for Surgical Oncology Conference Demonstrated DecisionDx ® -Melanoma Outperforms T-Stage at Identifying Patients with Low Risk of Sentinel Lymph Node Positivity.

March 11, 2022
·
7 min read
Biotech Bay

Sierra Oncology to Participate in the Oppenheimer 32nd Annual Healthcare Conference

Sierra Oncology, Inc. today announced the company will participate in the 32nd Annual Oppenheimer Healthcare Conference being held virtually from March 15-17, 2022.

March 11, 2022
·
1 min read